The ability of SGLT2 inhibitors to interact with the sodium-hydrogen exchanger NHE1 (Na+/H+ exchanger) may play an important role in myocardial remodeling in HF [57]. The gene discussed is SLC9A1; the disease is hydrops fetalis.